Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Miao

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Immunology|July 18, 2022
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
European Journal of Pharmacology|July 16, 2021
Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cellsHui Hu, Xiao-Wei Zhang, Lin Li, et al.
Cell Death & Disease|January 11, 2022
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFRXiao-Wei Zhang, Lin Li, Wen-Qian Hu, et al.
European Journal of Pharmacology|February 12, 2020
YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cellsHui Hu, Xiao-Kang Miao, Jing-Yi Li, et al.
The Journal of Biological Chemistry|March 26, 2017
β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G<sub>2</sub>/M phase transitionYi-Xin Zhang, Xiao-Fang Li, Guo-Qiang Yuan, et al.
Cell Death & Disease|June 29, 2023
Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancerXiao-Wei Zhang, Jing-Yi Li, Lin Li, et al.
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Immunology|July 18, 2022
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
European Journal of Pharmacology|July 16, 2021
Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cellsHui Hu, Xiao-Wei Zhang, Lin Li, et al.
Cell Death & Disease|January 11, 2022
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFRXiao-Wei Zhang, Lin Li, Wen-Qian Hu, et al.
European Journal of Pharmacology|February 12, 2020
YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cellsHui Hu, Xiao-Kang Miao, Jing-Yi Li, et al.
The Journal of Biological Chemistry|March 26, 2017
β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G<sub>2</sub>/M phase transitionYi-Xin Zhang, Xiao-Fang Li, Guo-Qiang Yuan, et al.
Cell Death & Disease|June 29, 2023
Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancerXiao-Wei Zhang, Jing-Yi Li, Lin Li, et al.
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
Pageof 3